CME Credit

1.25 CME credit: May 19th, 2022: 9:30-10:45am (EST): “Clarifying Cannabis: Considering the impact of recreational and medical use on cognitive and clinical outcomes”- Dr. Staci Gruber, Ph.D.

1.25 CME credit: May 19th, 2022: 1:00-2:15pm (EST): “Effects of THC and CBD: Implications for Future Clinical Trials”- Dr. Kent Hutchison, Ph.D.

1.25 CME credit: May 20th, 2022: 8:15-9:30am (EST): “Cannabis Use in Pain and as a Substitute for Opioids”- Dr. Samer Narouze, MD, Ph.D.

  • Learning objectives: As a result of participation in this activity, participants will be able to learn about:
    • The impact of marijuana on the brain using neurocognitive, clinical and diagnostic assessments
    • Effects of THC and CBD: Implications for Future Clinical Trials
    • Cannabinoids and Pain: what we know and future directions
  • Target audience: primary care physicians and specialty physicians
  • Accreditation statement: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • Credit statement: The University of Florida College of Medicine designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • Commercial support (grant/exhibit) acknowledgement:
    • This conference is supported by:
    • Exhibits: MUV Medical Cannabis Dispensary, RISE, FAMU Medical Marijuana Education and Research Initiative, GROFF North America, and OMMU (Office of Medical Marijuana Use)
    • Grants: None
  • Disclosure statement: Staci Gruber, Ph.D. has disclosed that she receives research support from Foria/Praxis Ventures and Charlotte’s Web, is a consultant for Greenwich Biosciences, and is a stock shareholder and on the advisory board for Ajna Biosciences. Planning committee member Almut Winterstein, R.Ph., Ph.D. has disclosed that she receives research support from Merck and Sharpe & Dohme, and was a consultant for Arbor Pharmaceuticals and Genentech, Inc. No one else in a position to control content has any financial relationships to disclose. Conflict of interest information for the CME Advisory Committee members can be found on the following website: https://cme.ufl.edu/disclosure/. All relevant financial relationships have been mitigated.

Event Search